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Using transient assays of chloramphenicol acetyltransferase expression i CV-1 cells, we have localized the 
human c-Ha-ras oncogene promoter to a 550 bp fragment located about 1 kb upstream from the ras coding 
sequence. Deletion analysis has revealed that a 100 nucleotide region 200 base pairs upstream of the putative 
initiation sites for transcription is essential for high levels of expression. Within this sequence lie two Spl 
binding sites and a consensus CCAAT box. 
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1. INTRODUCTION 
The oncogenic potential of the normal ras gene 
can either be activated by single point mutations 
[1] or by enhanced expression [2]. In certain cases, 
modulation of ras levels can be demonstrated dur- 
ing cellular transformation and tumor progression 
[3] and during liver regeneration [4] and can have 
profound effects on cell phenotype [5-7]. It is, 
therefore, important for our understanding of car- 
cinogenesis as well as our knowledge of gene ex- 
pression in general to delineate the cis-acting 
elements responsible for ras expression. 
With the exception of rapidly dividing cells, ex- 
pression of the ras gene remains relatively constant 
and low in most tissue types and throughout 
development [8]. Hence, the ras genes would ap- 
pear to fall into the broad class of ubiquitously ex- 
pressed genes generally termed 'housekeeping 
genes'. Recent experiments [9] have localized the 
promoter egion of the c-Ha-ras gene to a 550 base 
pair (bp) NaeI  fragment near the 5'-end of the 
genomic clone. Like other housekeeping enes 
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studied to date [10], the ras promoter is devoid of 
sequences traditionally observed in highly ex- 
pressed tissue-specific genes, but contains ix func- 
tional binding sites for the transcription factor Sp l  
[11]. In this study we have used deletion analysis to 
characterize further the sequences sential for c- 
Ha-ras expression using transient gene transfer 
techniques. 
2. MATERIALS AND METHODS 
2.1. P lasmid constructions 
The plasmid pBR-CAT was constructed by 
subcloning the Hind I I I -BamHI  fragment of 
pSV2-CAT [12] into the HindI I I  and BamHI  sites 
of pBR322. Promoter fragments were tested by 
subcloning into the HindI I I  site of pBR-CAT after 
addition of HindI I I  linkers. 
Deletions were constructed as follows: the 
550 bp NaeI fragment of c-Ha-ras (nucleotides 
116-666) was subcloned into the SmaI site of 
pUC18 in an orientation such that the pUC 
polylinker KpnI  site was upstream of the pro- 
moter. This plasmid, called pUCNaeI,  was partial- 
ly digested with HaeI I I  or Thai and ligated with 
BglII  linkers. The linkers could then be precisely 
positioned by restriction analysis. 5'-deletions 
were constructed by isolating Bgl I I -H ind I I I  
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fragments from distinct linker insertions and 
subcloning these into the HindlII site of pBR- 
CAT. 3 '-deletions were constructed by subcloning 
KpnI-BgllI fragments from these linker inser- 
tions. Internal deletions were made by digesting 
the linker-containing pUCNaeI plasmids with 
BgllI and ScaI, each of which will cut only once, 
and the two fragments obtained from each plasmid 
were recombined and ligated to generate a large 
variety of deletions joined by a BglII linker. These 
modified promoters were isolated as 
KpnI-HindlI I  fragments and subcloned into pBR- 
CAT. pSVO-CAT based deletions were con- 
structed by isolating BgllI-BamHI fragments 
from pUCNaeI linker insertions and subcloning 
these into pSVO-CAT. 
2.2. Chloramphenicol acetyltransferase assays 
Gene transfer was performed by calcium 
phosphate co-precipitation [13]. Chloramphenicol 
acetyltransferase (CAT) assays were performed as 
described [12]. Portions of the silica gel correspon- 
ding to acetylated chloramphenicol were cut out, 
dissolved in aqueous counting scintillant (Amer- 
sham) and counted on a Rackbeta 1211 liquid scin- 
tillation counter (LKB). All assays were performed 
under conditions which were linear for both DNA 
concentration and time of assay. Equivalent results 
were obtained from independent plasmid 
preparations. 
3. RESULTS 
Initial promoter mapping involved subcloning 
the entire 5'-region of the c-Ha-ras genomic lone 
from the BamHI site to the Sinai site within the 
5'-untranslated sequence (5'UT) (nucleotides 
0-1646 as numbered in [14]) to generate vector 
pBR-BSCAT. As shown in fig.l, the NaeI frag- 
ment (nucleotides 116-666) in plasmid pBR- 
NaeCAT had equivalent promoter activity to the 
entire fragment and must, therefore, contain the 
control sequences ufficient for expression of the 
ras gene. All subsequent studies then focused on 
this region. 
In order to delineate the sequences controlling c- 
Ha-ras expression, a series of deletions were con- 
structed in this 550 bp fragment. These were 
generated as described in section 2, and then 
subcloned into the CAT expression vectors to 
Fig.l. Localization of promoter activity. 10/zg of each 
plasmid was transfected into CV-I cells and the CAT 
activity of cell extracts was measured 48 h later as 
described [12]. The autoradiogram of a thin layer 
chromatography plate is shown. The mobilities of the 
acetylated (AcCM) and unacetylated (CM) forms of 
[~4C]chloramphenicol are shown. 
measure their relative promoter strength. The 
results of these experiments are shown in fig.2. 
Deletions from the 5'-end of the insert to 
nucleotide 196 consistently led to a small increase 
in CAT activity which was lost with further dele- 
tions beyond nucleotide 248. Deletion to 
nucleotide 375 led to a dramatic drop in CAT ac- 
tivity to background levels. Deletions from the 
3'-end to nucleotide 321 or beyond abolish 
transcription from the promoter and internal dele- 
tions further support hese results. Taken together, 
these results localize sequences necessary for 
transcription to a 100 bp region between 
nucleotides 275 and 375. In the opposite orienta- 
tion, the NaeI fragment gives rise to approximately 
a quarter as much CAT activity as in the correct 
orientation. 
Reports from another group have confirmed 
that the NaeI fragment utilized here does in fact 
contain sequences responsible for ras transcription 
[9]. In addition, this group went on to begin dele- 
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Fig.2. Deletion analysis of the c-Ha-ras promoter. The organization of the human c-Ha-ras gene is shown in the top 
line with the non-coding and coding exons represented by open and solid boxes respectively. Plasmid pBR-BSCAT 
contained the 1.6 kb BamHI/SmaI fragment encompassing the entire 5'-portion of the gene, while pBR-NaeCAT 
contains only 550 bp from nucleotide 116 to nucleotide 666. Shown on this segment is the location of the putative 
transcription i itiation sites (shown as an arrow) and the in vitro Sp! binding sites [ll] (shown as thick underlines). 
Beneath are deletion constructs inwhich the thin solid line represents the portion of the promoter remaining in the vector 
and vertical ines represent the position of BglII linkers. Vector pBR-eaNCAT contains the NaeI fragment in the 
inverted orientation relative to the CAT gene. The relative CAT activity of these constructs represents he percentage 
of CAT activity obtained from the complete ras promoter in pBR-NaeCAT. All values represent the means of two 
separate transfections which showed less than 10% variation. 
tion analyses of this fragment subcloned into the 
vector pSVO-CAT. They observed that a 
5'-deletion from nucleotide 116 to nucleotide 351 
had no effect on promoter activity and that dele- 
tion to nucleotide 427 reduced ras promoter activi- 
ty by only three quarters in CV-1 cells [ l l ] .  In 
contrast, we had found that deletions to nucleotide 
375 virtually abolished CAT activity. In order to 
better understand this discrepancy, we have 
reconstructed a number of the 5'-deletions of the 
ras promoter in pSVO-CAT. A direct comparison 
of pBR-CAT and pSVO-CAT based promoter- 
deletion vectors is shown in fig.3. Surprisingly, 
when these pSVO-CAT based vectors are 
transfected into CV-1 cells, CAT activity remains 
high even when the deletion to nucleotide 530 
(removing virtually all of the promoter sequence) is
tested. Furthermore, the level of ras-promoted 
CAT activity in this vector is only 3-4-fold above 
the vector background. 
4. DISCUSSION 
Using chimeric plasmid constructs we and others 
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Fig.3. Comparison of 5'-deletions in pBR-CAT and pSVO-CAT. The NaeI fragment containing the ras promoter and 
5 '-deletions of it were subcloned in front of the CAT genes in the promoterless vectors pBR-CAT and pSVO-CAT and 
assayed in CV-I cells as described in fig.l. The mobilities of acetylated (AcCM) and unacetylated (CM) forms of 
chioramphenicol are indicated. 
[9,11,15] have demonstrated that the 550 bp NaeI 
fragment contains ufficient information to permit 
expression of the c-Ha-ras oncogene. The c-Ha-ras 
promoter has a high GC content and contains 9 
consensus equences for the binding of transcrip- 
tion factor Spl [9]. Six sites have been shown to be 
functional binding sites for purified Spl in vitro 
centered around nucleotides 267, 294, 345, 405, 
514 and 525 [11]. As expected [16], the lack of a 
TATA box leads to transcriptional initiation from 
multiple sites at nucleotides 537, 549, 559 and 561 
in A431 cells [91. 
Deletions from either end of the promoter, or in- 
ternal deletions removing nucleotides 275-375 
(about 200 bp upstream from the putative start 
sites of transcription) had the most profound ef- 
fects on promoter activity. Although this region 
overlaps slightly with regions previously deter- 
mined to be sufficient for expression [l l] ,  major 
differences in results have been observed. The high 
transcriptional background of pSVO-CAT relative 
to pBR-CAT might have precluded the authors of 
the previous report from detecting significant dif- 
ferences following deletion of crucial sequences. 
The relationship of these deletions to the se- 
quences protected by Spl in vitro indicates that on- 
ly the two sites centered around nucleotides 295 
and 345 would be within the critical region. In- 
terestingly, within this stretch from nucleotide 362 
to nucleotide 368 lies the consensus equence for 
the CCAAT box, an element normally found 
about 70-80 nucleotides upstream from eucaryotic 
transcriptional start sites [17]. Further support for 
a functional role of this site comes from two recent 
studies. Jones et al. [18] have found that this ele- 
ment functions as a strong binding site for the 
transcription factor CTF in vitro. As well, the rat 
c-Ha-ras oncogene has recently been shown to con- 
tain two CCAAT boxes located at nucleotides 
- 100 and - 65 [19]. Thus, the c-Ha-ras oncogene 
may be an example of a distinct subset of 
housekeeping genes which utilize CCAAT boxes in 
conjunction with Spl binding sites. 
Although the CCAAT box described herein lies 
approx. 170 bp upstream from the putative initia- 
tion sites of the ras gene [9], the mapping of these 
sites has recently been brought into question [20]. 
Homology beween c-Ha-ras and v-Ha-ras extends 
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upstream beyond the putative transcriptional st rt 
sites to nucleotide 440 [20], a region only 80 bp 
downstream from the consensus CCAAT box. As 
the v-Ha-ras oncogene was probably transduced 
from a c-Ha-ras mRNA molecule, this argues that, 
at least in some cases, transcription must occur 
from sites other than those mapped. We are cur- 
rently examining the sites of transcriptional initia- 
tion from the ras promoter in vector pBR-NaeCAT 
and in normal cells to determine if they differ from 
those previously observed. 
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